Lung Cancer Clinical Trials

Clinical trials or research into new medicines and treatment approaches, are a vital part of our mission as an academic medical center. An active participant in national cancer research, the Thoracic Cancer Program team provides many patients with access to new therapies through clinical trials. These studies evaluate the latest chemotherapies for lung cancer, the best surgical approaches, radiation techniques, interventional radiology and combinations of these therapies.

Clinical trials try to determine which therapies, treatments and approaches work best, and there are always risks involved in any trial. Research tends to achieve small advances, which build over time.

Our specialists are national leaders in helping design and execute many national research studies. View a list of our current trials related to thoracic and chest cancers, including lung, esophagus and thymoma.

Current and Recent Studies

Medical Oncology (Chemotherapy): Chemotherapy is one of the most active areas of clinical research. Studies are always being conducted testing new drugs and testing, new ways to use existing drugs, in combination with other drugs, radiation, and surgery.

Radiation Therapy: The department of radiation oncology has several ongoing studies evaluating new technologies and appropriate use of new technologies in a clinical setting for radiation treatment planning and delivery. There are several ongoing studies evaluating the appropriate schedule and dose of radiation with standard techniques. Additionally, studies are being conducted to study the most effective way to combine radiation with chemotherapy and surgery.

The focuses of clinical studies in radiation oncology are to improve cancer control, to minimize the unwanted side effects of treatment, and improve treatment efficiency.

Surgery: Removing less of a lung or wedge resection vs. lobectomy. Much like breast cancer treatment has evolved away from mastectomies toward lumpectomies, studies are examining if taking out less of the lung can be as effective as a complete lobectomy.

Giving chemotherapy and radiation to shrink certain tumors before removing them surgically. Our results for operating after chemo and radiation have been good and our complication rates have been lower than expected. Those results are being reviewed to understand why are complications rates are so low.

Radiology: A Korean study demonstrated that injecting a small amount of iodinated dye into a very small lesion can help doctors find it more easily to perform a wedge resection. Our radiologists, because they are in touch with the latest research all over the world, began performing this procedure to help improve accuracy and patient care.

Interventional Radiology: Comparing the effectiveness of RFA (radiofrequency ablation) in patients with early stage lung cancer who are unable to have surgery.

Types of Clinical Trials

Phase I trials involve brand new drugs or treatments. These trials represent a minority of studies and are mainly suggested for patients who have failed other treatments or have cancer known to have little response to standard treatments. These studies test mainly for side effects.

Phase II trials test effectiveness of a newer treatment and how it may rank other treatments.

Phase III trials are the most sophisticated. They test one established effective treatment strategy against another that appears to be comparable to see which is better. Both of these treatment possibilities would likely benefit patients, but investigators truly do not know which is better until the trial is completed and analyzed.

To learn more about how clinical trials work, visit the National Comprehensive Cancer Network’s website.

Appointments

For lung and thoracic cancer treatment:

  • 414-805-0505
Request AppointmentView Treatment Team

Locations

Clinical Cancer Center, Froedtert Hospital 9200 W. Wisconsin Ave.
Milwaukee, WI 53226

Cancer Network

Health Library

Diseases and Conditions

  • The Genetics of Lung Cancer